Ignite Creation Date:
2024-05-06 @ 9:34 AM
Last Modification Date:
2024-10-26 @ 12:16 PM
Study NCT ID:
NCT03013543
Status:
COMPLETED
Last Update Posted:
2023-08-18
First Post:
2017-01-03
Brief Title:
Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity
Sponsor:
Rhythm Pharmaceuticals Inc
Organization:
Rhythm Pharmaceuticals Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Genetic Obesity |
| Obesity |
| Obesity Due to Melanocortin 4 Receptor Deficiency |